Organigram Holdings Stock Today
| OGI Stock | USD 1.05 0.03 2.78% |
PerformanceVery Weak
| Odds Of DistressLow
|
OrganiGram Holdings is trading at 1.05 as of the 20th of March 2025. This is a 2.78 percent decrease since the beginning of the trading day. The stock's open price was 1.08. OrganiGram Holdings has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. Organigram Hlds is traded on NASDAQ Exchange in the United States. The company has 133.78 M outstanding shares of which 4.3 M shares are now shorted by investors with about 4.43 days to cover. More on OrganiGram Holdings
Moving together with OrganiGram Stock
| 0.83 | VTRS | Viatris | PairCorr |
| 0.82 | NBIX | Neurocrine Biosciences | PairCorr |
| 0.88 | ELAN | Elanco Animal Health | PairCorr |
Moving against OrganiGram Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
OrganiGram Stock Highlights
| Old Name | OrganiGram Holdings Inc |
| Business Concentration | Pharmaceutical Products, Drug Manufacturers - Specialty & Generic, Healthcare, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
OrganiGram Holdings (OGI) is traded on NASDAQ Exchange in USA. It is located in 145 King Street West, Toronto, ON, Canada, M5H 1J8 and employs 1,093 people. OrganiGram Holdings is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 143.16 M. OrganiGram Holdings runs under Pharmaceuticals sector within Health Care industry. The entity has 133.78 M outstanding shares of which 4.3 M shares are now shorted by investors with about 4.43 days to cover.
OrganiGram Holdings has about 127.36 M in cash with 3.87 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check OrganiGram Holdings Probability Of Bankruptcy
Ownership AllocationOrganiGram Holdings owns a total of 133.78 Million outstanding shares. OrganiGram Holdings has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OrganiGram Ownership Details
OrganiGram Holdings Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. OrganiGram Holdings market risk premium is the additional return an investor will receive from holding OrganiGram Holdings long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | 0.9524 |
OrganiGram Stock Against Markets
OrganiGram Holdings Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Beena Goldenberg | CEO Director | Profile | |
| Helen Martin | Chief Secretary | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Megan McCrae | Senior Communications | Profile | |
| Amy Schwalm | VP Relations | Profile | |
| CFA CA | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.